clinical trial · NCT03003299
PARTNER 3 Trial - Aortic Valve-in-Valve
Edwards Lifesciences·N/A·recruiting·n = 125
Aortic StenosisAortic Stenosis, SevereEdwards SAPIEN 3/SAPIEN 3 Ultra THV
brief summary
This study will assess the safety and effectiveness of the SAPIEN 3/SAPIEN 3 Ultra transcatheter heart valve (THV) in patients with a failing aortic bioprosthetic valve.
started
Jan 5, 2017
primary completion
Jan 1, 2033
completion
Apr 1, 2038
last updated
May 10, 2024
detailed description
This is a prospective, single-arm, multicenter study.
official title
A Prospective, Single-Arm, Multicenter Study to Investigate the Safety and Effectiveness of SAPIEN 3/SAPIEN 3 Ultra Transcatheter Heart Valve Implantation in Patients With a Failing Aortic Bioprosthetic Valve
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol